Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients (Q79561522)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 November 2006

Language	Label	Description	Also known as
English	Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients	scientific article published on 27 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

based on heuristic

inferred from title

author name string

Xin Yao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Bojian Zheng

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Jie Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Dao-Zhen Xu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kai Zhao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Shu-Hui Sun

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Zheng-Hong Yuan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Yu-Mei Wen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

27 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1771-1779

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Transfusion of multi-factors activated immune cells as a novel treatment for patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Therapeutic efficacy of hepatitis B surface antigen–antibodies-recombinant DNA composite in HBsAg transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Antigen-antibody complex as therapeutic vaccine for viral hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Vaccination with recombinant HBsAg-HBIG complex in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Solid matrix-antibody-antigen complex can clear viraemia and antigenaemia in persistent duck hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.019

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.11.019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224217%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79561522&oldid=1775331408"